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PRELIMINARY AND SHORT REPORTS
EFFECT OF ADRENOCORTICOTROPIC HORMONE (ACTH) AND
CORTISONE ON THE SEVERAL VARIETIES OF PEMPHIGUS*
CHESTER N. FRAZIER, M.D., WALTER F. LEVER, l\/I.D., RoY W. LREPRR, M.D.,
CRARLES S. KRUPER, M.D., LESTER J. BIENVENU, M.D., JORN E. LEDONNR,
M.D., AND S. WILLIAM LEVY, M.D.
Since April, 1950, S patients with pemphigus have received treatment with adreno-
corticntropic hormone (ACTH) or cortisone. Three of the patients had the acute maligaant
form of pemphigus vulgaris, two had chronic pemphigus vulgaris, one had the vegetative
form of the disease (pemphigus vegetans), and two had exfoliative pemphigus (pemphigus
foliaceus).
CLINICAL DATA
Clinicel Response. Under treatment with ACTIHI or cortisone, all patients began to im-
prove within 3 to 5 days, provided an effective dose was administered. Continued treat-
ment caused further improvement to such an extent that few if any lesions remained.
Maximal improvement was reached within two to five weeks. Improvement was, however,
temporary. In most patients, new lesions began to appear approximately two weeks after
cessation of therapy; hot it took several additional weeks before the number and extent
of the lesions became appreciable. In 4 patients a minor exacerbation consisting of papules
and vesicles occurred within two or three days after cessation of treatment but subsided
spontaneously in a few days. In all 5 patients in whom treatment with ACTH was started
more than two months ago a second course of ACTH or cortisone has already been neces-
sary; and to one of these patients, affected with pemphigus foliaceus, even a third course
has had to be given. Response on readministration was as good as with the first course. In
fact, smaller doses were usually effective, probably because the patients were not allowed
to relapse to as severe a state of involvement as had been present on the first administra-
tion. The shortest interval between first and second courses of treatment was 23 days.
One patient with acute pemphigus vulgaris has now been in remission for over 160 days
after having received two courses of ACTH.
No serious side effects developed in any of the patients. In one patient with pemphigus
foliaceus, acute glomerulonephritis developed in the interval between a course of ACTH
and a course of cortisone. This was probably precipitated by a preceding secondary pyo-
genie infection of the skin and improved, or at least grew no worse, during the administra-
tion of cortisone. No mental disturbances were observed except mild euphoria which oc-
curred in most patients. This was usually followed by mild depression on withdrawal of the
drug. Distinct hyperpigmentation of the involved skin appeared with ACTH in 3 patients
of Mediterranean stock but diminished following cessation of treatment. A suggestion of
"moon face" was present in all patients receiving ACTH or cortisone.
Dosage. ACTH was administered in equally divided doses every six hours to 2 patients
with acute pemphigus vulgaris, 2 patients with chronic pemphigus vulgaris, 1 patient with
pemphigus vegetans, and 2 patients with pemphigus foliaeeus. In all patients but one with
pemphigus foliaeeus a daily dose of 200 mgm. was adequate to cause complete or nearly
complete involution of the lesions (Fig. 1). The one patient with pemphigus foliaeeus did
not improve during 14 days' treatment with 200 mgm. of ACTH per day, but improved
within three days when the daily dose was raised to 300 mgm. (Fig. 2). Two patients, one
* From the Department of Dermatology, Harvard Medical School, and the Dermatologi-
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FIG. 1. Condition of the skin of patient E. S. before and after treatment with adreno-
corticotropic hormone and cortisone.
FIG. 2. Condition of the skin of patient H. C. with pemphigns foliaceus before and after
treatment with adrenocorticotropic hormone and cortisone.
with acute pemphigus vulgaris and one with chronic pemphigus vulgaris, at first received
only 100 mgm, of ACTH daily for one week without clinical improvement, suggesting that
as a rule this dose is inadequate.
Cortisone was administered intramuscularly to the 2 patients with pemphigus foliaceus
during a relapse and to one new patient with acute pemphigus vulgaris. In the 2 patients
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CHART 1. Response of patient B. A. (acute pemphigus vulgaris) to adrenocorticotropic
hormone.
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TABLE 1
Physiological responses of patients with pemphigus treated with adrenocorticotro pie hormone
(.4CTH) or cortisone
H
ADMIN- N
ISTEA-
TION
H
MAXIMAL
CHANGE IN
EOSINO-
PUlLS
MAXIMAL
CHANGE IN
SEDIMENT.
RATE
MAXIMALMAXIMAL CHANGECHANGE IN IN 17-
WEIGHT EETOSTEEOIDS
NAME
B. A *
E. S.f
S. A.
P. L.
I. D.
H. S.
W. K.
H. C4
DIAGNOSIS TYPE OS'
Pemphigus vulgaris ACTH
acutus ACTH
Pemphigus vulgaris ACTH
acutus Cort.
Pemphigus vulgaris Cort.
acutus
Pemphigus vulgaris ACTH
chronicus
Pemphigus vu1garis ACTH
chronicus
Pemphigus ACTH
vegetans ACTH
Pemphigus ACTH
foliaceus Cort.
Pemphigus ACTH
foliaceus ACTH
Cort.
lbs.
147 —. 155
137 —* 134
122 —. 125
123 —.* 126
132 —. 124
137 240
Gms.
2.85
1.0
5.7
3.38
8.6
1.38
2.6
1.38
1.28
5.5
3.25
8.15
1.25
5.8
i.m.
i.m.
i.rn.
P.O.
i.m.
i.m.
i.m.
I i,m.
i.m.
i.m.
i.m.
i.m.
i.nI.
Sm.
551gm. per 240,. urine
1.4—s 8.0
0 — 17.6
0.4 — 1.8
days
22
5
30
16
33
11
15
11
10
33
20
46
7
28
per Cu. mm.
917 —s 3
58 —. 5
484 —. 0
262 — 0
2551 — 33
478 —. 6
192—2
1637 — 43
415 — 0
270 —e 94
628 —. 0
212 —s 4
282 —. 4
mm. er miss.
0.4 —0.8
0.8 —.0.1
0.7 -.0.2
0.35 —0.2
0.7 —.0.12
1.2 —0.35
1.4 —0.5
1.7 —0.7
0.85 —.0.2
189—192 10.2— 19.6
195 — 202
131 — 148
156 — 164
117— 97
118 —. 112
1.7 —24.8
2.0 —s 9.6
* See Chart 1.
See Chart 2 and Fig. 1.
See Fig. 2.
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with pemphigus foliaceus 300 mgm. per day was found to be effective within two weeks.
However, the patient with acute pemphigus vulgaris improved only slightly on 300 mgm.
of cortisone per day for twelve days; she became free of new lesions five days after the
daily dose was raised to 400 mgm. per day. Cortisone orally in a dose of 300 mgm. per day
was given to another patient with acute pemphigus vulgaris during a relapse and improve-
ment began within five days.
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CHART 2. Response of patient E. S. (acute pemphigus vulgaris) to adrenocorticotropic
hormone.
LABORATORY DATA
Bosinophil Counts. Blood for eosinophil counts was drawn while the patients were fast-
ing and usually two to three hours after the first dose of ACTH or cortisone of the day.
In 6 patients the initial eosinophil count was less than 1,000 per cu. mm. (Table 1). In these
patients, with one exception, clinically effective doses of ACTH or cortisone reduced the
eosinophil count to values below 10 (Chart 1). In the one exception, the lowest count was
94. In 2 patients the initial eosinophil count was well above 1,000 per en. mm. In one of
them, who had pemphigus vegetans, the count was 1,837 per Cu. mm. it fell to 43 under
therapy with 200 mgm. of ACTH per day. In the other patient, who had acute pemphigus
vulgaris, the count was 2,551 per cu. mm.; no significant decrease occurred under treat-
ment with 300 mgm. of cortisone intramuscularly per day. However, when the dose was
increased to 400 mgm. per day, the count dropped to 33 per cu. mm. In some instances, the
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eosinophil counts rose to pretreatment levels two or three days after omission of the drugs
(Chart 1). The impression was gained that adequate clinical improvement occurred only
with doses of ACTII or cortisone sufficiently large to cause a considerable decrease in the
number of eosinophils.
Erythrocyte Sedimentation Rate. Serial determinations of the sedimentation rate were
made on 5 patients. The rate was elevated in all (Table 1). In 4 patients the rate decreased
to normal as clinical improvement occurred (Chart 2). The rate remained elevated in one
patient in whom some oral lesions persisted after the cutaneous lesions had healed. It is
felt that the sedimentation rate represents a fairly accurate indicator of the response of
the patient with pemphigus to ACTH or cortisone.
Urinary Excretion of 17-ketosteroids. The excretion of the 17-ketosteroids per 24 hours
in the urine was determined in 6 patients before and after treatment with ACTH. In all,
a rise in excretion was noted after treatment (Table 1).
Serum Electrolytes. In 2 patients a significant decrease in the amount of serum potassium
occurred during treatment with ACTH, namely from 4.3 to 3.0 mEq./L. in one patient, and
from 4.6 to 2.5 mEq./L. in the other. In both patients electrocardiographic changes con-
sistent with hypokalemia were noted. These changes reverted to normal with the oral
administration of 3 to 4 Gm. of potassium chloride per day. In several patients potassium
chloride was given orally as a prophylactic measure.
Plasma Proteins. A moderate to marked decrease in total plasma proteins to values
below 5.6 Gm./l00 ml. was observed in 6 patients. Two patients, one with chronic pemphi-
gus vulgaris and one with pemphigus vegetans, had values within the normal range. Clini-
cal improvement under therapy was associated with a rise in the total protein. Electro-
phoretic analyses before and after therapy were carried out in 5 patients (Table 2). Before
therapy the albumin was lowered in all instances, whereas the alpha-l, alpha-2 and gamma
globulins were elevated. As a rule, the electrophoretic patterns changed toward normal
without, however, becoming entirely normal.
Water Balance. Water retention, reflected by a gain in weight amounting to 8 pounds or
more was noted in 3 of the patients (Table 1).
Blood Pressure. No significant increase in blood pressure was observed in any of the
patients.
Blood Sugar. No rise in the fasting blood sugar was observed nor was there any signifi-
cant renal excretion of glucose.
